The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA, USDA, EPA announce the signing of a formal agreement to renew their Federal interagency Collaboration to Reduce Food Loss and Waste (FIFLAW) and welcome USAID making a significant expansion of the federal collaboration.

FDA reached a significant milestone with approval of its reorganization involving the creation of a unified HFP, adoption of a new model for its field operations and other significant modernization efforts.

FDA approved Bkemv as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH); and atypical hemolytic uremic syndrome (aHUS).

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.